NSF-gadolinium cases centralized.(Policy & Practice)(nephrogenic systemic fibrosis )(Brief article)

From: Skin & Allergy News | Date: May 1, 2008| Author: | Copyright information

Discovery for 66 suits alleging that gadolinium-based contrast led to nephrogenic systemic fibrosis (NSF) has been consolidated in a federal court in Ohio. The plaintiffs allege that the gadolinium-based contrast agent used during magnetic resonance imaging led to NSE NSF has occurred only in patients with preexisting renal compromise. The Food and ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

MR contrast tied to skin syndrome.(News)(magnetic resonance)
; Gadolinium-based contrast agents, when...disease called nephrogenic systemic fibrosis or...MRA) with a gadolinium-based contrast agent. Many...progress to nephrogenic systemic fibrosis...unaware that nephrogenic systemic fibrosis may...reaction ...
MR contrast agent poses danger in renal disease.(Clinical Rounds)
; Gadolinium-based contrast agents, when...disease called nephrogenic systemic fibrosis or...MRA) with a gadolinium-based contrast agent. Many...progress to nephrogenic systemic fibrosis...unaware that nephrogenic systemic fibrosis may...reaction ...
Contrast agents may pose danger in renal disease.(Clinical Rounds)(Disease/Disorder overview)
; Gadolinium-based contrast agents, when...disease called nephrogenic systemic fibrosis or...MRA) with a gadolinium-based contrast agent. Many...progress to nephrogenic systemic fibrosis...unaware that nephrogenic systemic fibrosis may...reaction ...
Retired Cleveland Businessman Sues Tyco International for Rare Disease Caused by its MRI Drug, Optimark Through Law Firm of Spangenberg, Shibley & Liber
; ...disease known as Nephrogenic Systemic Fibrosis (NSF). The...reports worldwide of Nephrogenic Systemic Fibrosis, also sometimes...patient exposure to gadolinium-based contrast agents, including...the use of certain gadolinium-based contrast agents, ...
MR contrast, renal dermopathy linked.(Clinical Rounds)(magnetic resonance)(Clinical report)
; Gadolinium-based contrast agents, when...disease called nephrogenic systemic fibrosis or...MRA) with a gadolinium-based contrast agent. Many...to the FDA. Nephrogenic fibrosing dermopathy...progress to nephrogenic systemic fibrosis (NSF...received a ...
In renal disease patients, think twice before MRI: nephrogenic systemic fibrosis appears to increase with use of contrast agents, especially Omniscan.(Autoimmunity/Connective Tissue)
; ...deal with nephrogenic systemic fibrosis...receiving gadolinium-based contrast agents administered...Kanal said. Nephrogenic systemic fibrosis...administered dose of gadolinium-based contrast agent. The...
Boxed warning: renal fibrosis risk with gadolinium contrast agents.(News)
; ...increased risk of nephrogenic systemic fibrosis in patients...to the labels of gadolinium-based contrast agents, according...the five marketed gadolinium-based contrast agents...imaging. The risk of nephrogenic systemic fibrosis (NSF) has...cause is known: ...
Nephrogenic systemic fibrosis risk leads to boxed warning for contrast agents.(News)
; ...the increased risk of nephrogenic systemic fibrosis in patients...added to the labels of gadolinium-based contrast agents, according to...of the five marketed gadolinium-based contrast agents (GBCA...imaging. The risk of nephrogenic systemic fibrosis (NSF) ...
Infection may increase risks from contrast agents: researchers assessed patients with chronic kidney disease who developed nephrogenic systemic fibrosis.(Clinical Rounds)
; ...development of nephrogenic systemic fibrosis...administration of gadolinium-based contrast agents. Eight...developing nephrogenic systemic fibrosis...There are five gadolinium-based contrast agents approved...
Education update: contrast-enhanced neuroimaging.(MRI & CT)
; ...neuroimaging to the safety of using gadolinium-based contrast agents. [ILLUSTRATION OMITTED] Emanuel...compared the safety of FDA-approved gadolinium-based contrast agents and looked at how best to minimize the risk of a patient developing nephrogenic systemic fibrosis ...